Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (261-270 of 1,111) with videos related to

Pageof 112
Sort By:
Clinical Cardiology|July 20, 2010
Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH RegistryEfraín Gaxiola, Luis Eng-Ceceña, Fernando Ortiz-Galván, et al.
European Journal of Preventive Cardiology|April 1, 2011
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH RegistryJean Dallongeville, Deepak L Bhatt, P H Gabriel Steg, et al.
European Journal of Preventive Cardiology|February 24, 2021
Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smokingAlexandre Gautier, Gregory Ducrocq, Yedid Elbez, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2015
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trialPascal Vranckx, Marco Valgimigli, Stephan Windecker, et al.
European Journal of Preventive Cardiology|January 8, 2023
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromesEmmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, et al.
American Heart Journal|March 25, 2014
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trialMarc P Bonaca, Deepak L Bhatt, Eugene Braunwald, et al.
Circulation. Cardiovascular Quality and Outcomes|October 14, 2010
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United StatesElizabeth M Mahoney, Kaijun Wang, Hong H Keo, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
American Heart Journal|April 21, 2009
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trialMark J Sculpher, Greta Lozano-Ortega, Jennifer Sambrook, et al.
Pageof 112

Showing results (261-270 of 1,111) with videos related to

Sort By:
Pageof 112
Clinical Cardiology|July 20, 2010
Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH RegistryEfraín Gaxiola, Luis Eng-Ceceña, Fernando Ortiz-Galván, et al.
European Journal of Preventive Cardiology|April 1, 2011
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH RegistryJean Dallongeville, Deepak L Bhatt, P H Gabriel Steg, et al.
European Journal of Preventive Cardiology|February 24, 2021
Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smokingAlexandre Gautier, Gregory Ducrocq, Yedid Elbez, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2015
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trialPascal Vranckx, Marco Valgimigli, Stephan Windecker, et al.
European Journal of Preventive Cardiology|January 8, 2023
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromesEmmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, et al.
American Heart Journal|March 25, 2014
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trialMarc P Bonaca, Deepak L Bhatt, Eugene Braunwald, et al.
Circulation. Cardiovascular Quality and Outcomes|October 14, 2010
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United StatesElizabeth M Mahoney, Kaijun Wang, Hong H Keo, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
American Heart Journal|April 21, 2009
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trialMark J Sculpher, Greta Lozano-Ortega, Jennifer Sambrook, et al.
Pageof 112